Valuation: Orgenesis Inc.

Market Cap 985K 875K 818K 746K 1.4M 94.86M 1.42M 9.9M 3.83M 48.31M 3.7M 3.62M 155M P/E 2023
-0.26x
P/E 2024 -0.17x
Enterprise Value 19.17M 17.02M 15.92M 14.51M 27.31M 1.85B 27.69M 193M 74.55M 940M 71.96M 70.4M 3.02B EV / Sales 2023
71.2x
EV / Sales 2024 27x
Free-Float
52.06%
Yield 2023 *
-
Yield 2024 -
1 week+724.59%
1 month+57.14%
3 months+37.50%
6 months-8.33%
Current year+266.67%
1 week 0.55
Extreme 0.55
0.67
1 month 0.03
Extreme 0.0327
0.7
Current year 0
Extreme 0.001
0.84
1 year 0
Extreme 0.001
1
3 years 0
Extreme 0.0001
10.8
5 years 0
Extreme 0.0001
52
10 years 0
Extreme 0.0001
168
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 72 2012-02-01
Chief Executive Officer 57 2013-12-23
Director of Finance/CFO 51 2026-03-09
Director TitleAgeSince
Chairman 57 2014-08-13
Director/Board Member 64 2024-07-07
Director/Board Member 47 2024-10-27
Date Insider Type Main position Quantity % Market Cap. Importance
3/5/25 Other 1,200,000 23.2142%
12/12/24 Free

Director

1,500 0.0290%
12/12/24 Free

Director

1,835 0.0355%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+724.59%-30.38%-91.13% 5.39M
-2.17%-4.33%-27.56%-0.17% 167B
+0.17%-2.34%-8.83%+10.31% 111B
-0.88%+1.19%-25.04%-0.11% 105B
+0.17%+0.63%-48.32%-11.52% 74.82B
+3.17%-0.03%-0.64%+72.13% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.52%-0.65%-6.74%-31.12% 48.5B
-0.85%+0.85%-16.51%+18.41% 40.79B
-0.07%-1.42%+30.49%-7.58% 32.54B
Average -0.19%+72.32%-11.99%+1.87% 69.02B
Weighted average by Cap. -0.50%-0.91%-16.18%+9.53%

Financials

2023 2024
Net sales 530K 471K 440K 401K 755K 51.03M 766K 5.33M 2.06M 25.99M 1.99M 1.95M 83.47M 1.03M 919K 860K 783K 1.47M 99.65M 1.5M 10.4M 4.03M 50.75M 3.89M 3.8M 163M
Net income -55.36M -49.17M -45.98M -41.9M -78.89M -5.33B -79.97M -556M -215M -2.71B -208M -203M -8.72B -48.16M -42.78M -40.01M -36.46M -68.64M -4.64B -69.58M -484M -187M -2.36B -181M -177M -7.59B
Net Debt 21.78M 19.35M 18.09M 16.49M 31.04M 2.1B 31.47M 219M 84.74M 1.07B 81.79M 80.01M 3.43B 18.18M 16.15M 15.1M 13.76M 25.91M 1.75B 26.26M 183M 70.72M 891M 68.26M 66.78M 2.86B
Logo Orgenesis Inc.
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.
Employees
77
Date Price Change Volume
26-10-01 $0.5500 0.00% 100
26-09-30 $0.5500 -5.17% 100
26-09-29 $0.5800 -13.11% 150
26-09-28 $0.6675 +33.50% 100
26-09-25 $0.5000 +649.63% 140
  1. Stock Market
  2. Stocks
  3. ORGS Stock